NSF
SBIR Phase II: Mechanically Controlled Therapeutics Delivery Platform
SBIR Phase II: Mechanically Controlled Therapeutics Delivery Platform is a funding opportunity from NSF, closing July 31, 2028.
Jul 31, 2028
(732d left)Overview
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to develop a force-stimulated delivery platform. This platform utilizes mechano-activated microcapsules combined with the natural mechanical forces of the joint for the controlled and directed delivery of…